Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Newtopia Inc

NEWUF:QBB

Newtopia Inc

Actions
  • Price (USD)0.0055
  • Today's Change0.00 / 0.00%
  • Shares traded13.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024 20:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Newtopia Inc. is a Canada-based technology-enabled whole health platform company helping people create positive lifelong habits that prevent, slow, or reverse chronic disease while reducing healthcare costs for health insurers. The platform leverages genetic, social and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, the Company delivers sustainable clinical and financial outcomes. Its personalized habit change platform focuses on physical and mental health risk reduction. Each personalized program aims to sustainably reduce the primary metabolic risk factors of chronic disease, including waist circumference, blood glucose, triglycerides, and cholesterol, along with mental and emotional health risk factors.

  • Revenue in CAD (TTM)8.16m
  • Net income in CAD-6.38m
  • Incorporated2008
  • Employees100.00
  • Location
    Newtopia Inc33 Bloor Street East, 5th FloorTORONTO M4W 3H1CanadaCAN
  • Phone+1 (416) 223-0212
  • Websitehttps://www.newtopia.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.